SCHEMBL25906333

SCHEMBL25906333

CC(=O)CCc1cc(C(C)C)ccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.49
HSP90AB1 P08238 2/20 0.49
IAPP P10997 1/20 0.47
RNASEH1 O60930 1/20 0.46
ALDH1A1 P00352 4/20 0.44
GAA P10253 4/20 0.44
HTT P42858 3/20 0.44
ALOX12 P18054 2/20 0.44
HIF1A Q16665 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
XBP1 P17861 1/20 0.42
TYR P14679 3/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 1/20 0.42
TRPA1 O75762 1/20 0.42
PTGS1 P23219 1/20 0.42
CACNA1C Q13936 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22888381 0.85 HSP90AA1 (0.48) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL25906332 0.83 RNASEH1 (0.49) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL25906284 0.79 HSP90AA1 (0.43) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL5166281 0.79 ALDH1A1 (0.50) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL6160355 0.79 IAPP (0.53) IAPPALDH1A1ALOX12HIF1ACYP3A4
SCHEMBL18044790 0.79 ALDH1A1 (0.50) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL5167176 0.78 RNASEH1 (0.55) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL50460 0.76 ALDH1A1 (0.55) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL5166613 0.76 TYR (0.49) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA
SCHEMBL17026838 0.76 TRPA1 (0.48) HSP90AA1HSP90AB1RNASEH1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713335-B2 Aminocoumarin compounds and methods of their use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713335-B2 Aminocoumarin compounds and methods of their use AAAS, PROC, AADAC HSP90AA1 1344/4885HSP90AB1 1341/4885IAPP 4616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.